Carbacyclin-d4

69609-77-4(unlabelled)

CS-T-103365

C₂₁H₃₀D₄O₄

354.52

CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(C2)=C\CC([2H])([2H])C([2H])([2H])C(O)=O

Stable Isotopes

Carbacyclin

Refer MSDS for complete information.

[3aS-[2E,3aα,4α(1E,3R*),5β,6aα]]-5-[Hexahydro-5-hydroxy-4-(3-hydroxy-1-octenyl)-2(1H)-pentalenylidene]-pentanoic Acid-d4; (5E)-5-[(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-1-octenyl]-2(1H)-pentalenylidene]pentanoic Acid-d4; (+)-Carbacyclin-d4; (5E)-6a-Carbaprostaglandin I2-d4; 5(E)-Carbacyclin-d4; Carba-PGI2-d4; Carbacyclin-d4; Carbaprostacyclin-d4; Carboprostacyclin-d4;

Churchman, M. et al.: Cancer Cell., 28, 343 (2015); Ghandour, R. et al.: Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1861, 285 (2016);

[3aS-[2E,3aα,4α(1E,3R*),5β,6aα]]-5-[Hexahydro-5-hydroxy-4-(3-hydroxy-1-octenyl)-2(1H)-pentalenylidene]-pentanoic Acid-d4; (5E)-5-[(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-1-octenyl]-2(1H)-pentalenylidene]pentanoic Acid-d4; (+)-Carbacyclin-d4; (5E)-6a-Carbaprostaglandin I2-d4; 5(E)-Carbacyclin-d4; Carba-PGI2-d4; Carbacyclin-d4; Carbaprostacyclin-d4; Carboprostacyclin-d4;

Isotope labelled Carbacyclin acts as a converter of human white to bright adipocytes. Also used in the treatment of high-risk acute lymphoblastic leukemia potentiating the activity of anti-cancer therapeutics.

Refer MSDS for complete information.